Molekule Group Performance
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Molekule are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Molekule Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Molekule is not utilizing all of its potentials. The recent stock price mess, may contribute to short-term losses for the institutional investors. ...more
| Begin Period Cash Flow | 17.6 M | |
| Total Cashflows From Investing Activities | -506.6 K |
Molekule |
Molekule Relative Risk vs. Return Landscape
If you would invest (100.00) in Molekule Group on December 21, 2024 and sell it today you would earn a total of 100.00 from holding Molekule Group or generate -100.0% return on investment over 90 days. Molekule Group is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Molekule, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Molekule Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Molekule's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Molekule Group, and traders can use it to determine the average amount a Molekule's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MKUL |
Based on monthly moving average Molekule is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Molekule by adding Molekule to a well-diversified portfolio.
Molekule Fundamentals Growth
Molekule Stock prices reflect investors' perceptions of the future prospects and financial health of Molekule, and Molekule fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Molekule Stock performance.
| Return On Equity | -1.17 | |||
| Return On Asset | -0.25 | |||
| Profit Margin | (1.53) % | |||
| Operating Margin | (1.47) % | |||
| Current Valuation | 45.01 M | |||
| Shares Outstanding | 34.65 M | |||
| Revenue | 48.03 M | |||
| EBITDA | 8.34 M | |||
| Total Debt | 46.72 M | |||
| Book Value Per Share | 1.20 X | |||
| Cash Flow From Operations | (41.28 M) | |||
| Earnings Per Share | (0.68) X | |||
| Total Asset | 52.32 M | |||
| Retained Earnings | (7.92 M) | |||
Things to note about Molekule Group performance evaluation
Checking the ongoing alerts about Molekule for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Molekule Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Molekule Group is not yet fully synchronised with the market data | |
| Molekule Group has some characteristics of a very speculative penny stock | |
| Molekule Group has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 48.03 M. Net Loss for the year was (1.55 M) with profit before overhead, payroll, taxes, and interest of 277.62 K. | |
| Molekule generates negative cash flow from operations | |
| About 33.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Molekule's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Molekule's stock is overvalued or undervalued compared to its peers.
- Examining Molekule's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Molekule's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Molekule's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Molekule's stock. These opinions can provide insight into Molekule's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Molekule Stock
If you are still planning to invest in Molekule Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Molekule's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |